Jentarra GM, Heck MC, Youn JW, Kibler K, Langland JO, Baskin CR, Ananieva O, Chang Y, Jacobs BL. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination. Vaccine (2008).
Gallegos-Orozco JF, Arenas JI, Vargas HE, Kibler KV, Wilkinson JK, Nowicki, M, Radkowski M, Nasseri J, Rakela J, Laskus T. Selection of different 5'untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection. J Viral Hep (2006).
.Y. Jin, V. Giordano, K.V. Kibler, H. Nakano, and K.T. Jeang. Role of Adapter Function in Oncoprotein-mediated Activation of NF-?B. The Journal of Biological Chemistry (1999).
K.V. Kibler and K. T. Jeang. Taxing the Cellular Capacity for Repair: Human T-Cell Leukemia Virus Type 1, DNA Damage, and Adult T-Cell Leukemia. Journal of the National Cancer Institute (1999).
K. V. Kibler, T. Shors, K. B. Perkins, C.C. Zeman, M.P. Banaszak, J. Biesterfeldt, J. O. Langland, and B. L. Jacobs. 1997. Double-Stranded RNA Is a Trigger for Apoptosis in Vaccinia Virus-Infected Cells. Journal of Virology, 71(3):1992-2003. Journal of Virology (1997).
Teri Shors, Karen V. Kibler, Kim B. Perkins, Renee Seidler-Wulff, Matthew P. Banaszak, and Bertram L. Jacobs. Complementation of Vaccinia Virus Deleted of the E3L Gene by Mutants of E3L. Virology (1997).
Research Activity
Jacobs,Bertram Lewis*, Kibler,Karen. A Novel Replication Competent Flavivirus-based HIV Vaccine Platform ie RepliVax as a Priming Component for Improving Antibody Response. CHUV(9/6/2012 - 8/31/2016).
